A combined Clostridium perfringens/Trueperella pyogenes inactivated vaccine induces complete immunoprotection in a mouse model

被引:20
作者
Zhang, Wenlong [1 ,2 ]
Wang, Pu [1 ,2 ]
Wang, Bing [1 ,2 ]
Ma, Bo [1 ,2 ]
Wang, Junwei [1 ,2 ]
机构
[1] Northeast Agr Univ, Dept Vet Prevent Med, Coll Vet Med, Harbin 150030, Heilongjiang, Peoples R China
[2] China Minist Agr, Northeast Sci Inspect Stn, Key Lab Anim Pathogen Biol, Beijing, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Clostridium perfringens; Trueperella pyogenes; Combined inactive vaccine; Immunoprotection; PERFRINGENS PHOSPHOLIPASE-C; ARCANOBACTERIUM-PYOGENES; TRUEPERELLA-PYOGENES; CHIMERIC PROTEIN; GAS-GANGRENE; PYOLYSIN; INFECTION; TOXINS; ALPHA; IDENTIFICATION;
D O I
10.1016/j.biologicals.2017.04.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Clostridium perfringens (C perfringens) and Trueperella pyogenes (T pyogenes) are two bacterial pathogens frequently associated with wound infections and following lethal complications in livestock. However, prudent use of antimicrobial agents is highly required given the emergence of multidrug-resistant strains of both bacteria and need for food safety. In the current study, a combined vaccine, composed of inactivated C perfringens and T pyogenes, was prepared. The amount of formaldehyde being used to inactivate two bacteria was optimized to retain the immunogenicity of antigens. Three adjuvants were tested for their potency in improving specific immune responses against the candidate antigens. Then inactivated combined C perfringens IT. pyogenes vaccine was prepared using inactive cultures of two organisms. The ratio of inactive cultures of two organisms for preparation of combined vaccine was optimized to gain effective protective immunity against the two pathogens. Results revealed that combined C perfringens pyogenes inactive vaccine can elicit high level of exotoxins and cell-associated antigen specific antibodies and induce complete protection against C perfringens and T pyogenes infections in mice. The combined vaccine could be used as an alternative of antibiotics for prevention of C perfringens and T pyogenes infections in animals. (C) 2017 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 30 条
[1]  
Abu-Samra Mukhtar Taha, 2014, Vet Med Int, V2014, P413719, DOI 10.1155/2014/413719
[2]   Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies [J].
Alam, Syed Imteyaz ;
Bansod, Sunita ;
Singh, Lokendra .
BMC MICROBIOLOGY, 2008, 8 (1)
[3]   PROPERTIES AND ANTIMICROBIAL SUSCEPTIBILITY OF TRUEPERELLA PYOGENES ISOLATED FROM BOVINE MASTITIS IN CHINA [J].
Alkasir, Rashad ;
Wang, Jianfang ;
Gao, Jian ;
Ali, Tariq ;
Zhang, Limei ;
Szenci, Otto ;
Bajcsy, Arpad Csaba ;
Han, Bo .
ACTA VETERINARIA HUNGARICA, 2016, 64 (01) :1-12
[4]   Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene [J].
Awad, MM ;
Ellemor, DM ;
Boyd, RL ;
Emmins, JJ ;
Rood, JI .
INFECTION AND IMMUNITY, 2001, 69 (12) :7904-7910
[5]   Molecular characterization of the pore-forming toxin, pyolysin, a major virulence determinant of Arcanobacterium pyogenes [J].
Billington, SJ ;
Songer, JG ;
Jost, BH .
VETERINARY MICROBIOLOGY, 2001, 82 (03) :261-274
[6]   Identification of fimbrial subunits in the genome of Trueperella pyogenes and association between serum antibodies against fimbrial proteins and uterine conditions in dairy cows [J].
Bisinotto, R. S. ;
Oliveira Filho, J. C. ;
Narbus, C. ;
Machado, V. S. ;
Murray, E. ;
Bicalho, R. C. .
JOURNAL OF DAIRY SCIENCE, 2016, 99 (05) :3765-3776
[7]   Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia [J].
Bokori-Brown, Monika ;
Hall, Charlotte A. ;
Vance, Charlotte ;
da Costa, Sergio P. Fernandes ;
Savva, Christos G. ;
Naylor, Claire E. ;
Cole, Ambrose R. ;
Basak, Ajit K. ;
Moss, David S. ;
Titball, Richard W. .
VACCINE, 2014, 32 (23) :2682-2687
[8]   Wound microbiology and associated approaches to wound management [J].
Bowler, PG ;
Duerden, BI ;
Armstrong, DG .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (02) :244-+
[9]   Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines [J].
Brandi, Igor Viana ;
Mozzer, Otto Domenici ;
Vander Jorge, Edson ;
Vieira Passos, Frederico Jose ;
Lopes Passos, Flavia Maria ;
Rodrigues Cangussu, Alex Sander ;
Sobrinho, Eliane Macedo .
BIOPROCESS AND BIOSYSTEMS ENGINEERING, 2014, 37 (09) :1737-1742
[10]  
Bryant A, 2015, Molecular Medical Microbiology, P899